These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9701454)

  • 21. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein(a): from molecules to therapeutics.
    Bermúdez V; Arráiz N; Aparicio D; Rojas E; Gotera D; Guerra X; Canelón R; Faría J; Sorell L; Amell A; Reyna N; Cabrera M; Mengual E; Cano R; Cano C; Velasco M
    Am J Ther; 2010; 17(3):263-73. PubMed ID: 20479580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Apolipoprotein (a) phenotypes of patients with myocardial infarction].
    Zhong Y; Li J; Wang J
    Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):149-51; 190. PubMed ID: 7780820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.
    Ribault A; Durou MR; Letellier C; Wojcik F; Poirier JY; Ruelland A
    Diabetes Metab; 2000 Apr; 26(2):107-12. PubMed ID: 10804324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) and other risk factors for cerebral infarction.
    Konemori G
    Hiroshima J Med Sci; 1995 Sep; 44(3):65-77. PubMed ID: 8567315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
    Gazzaruso C; Bruno R; Pujia A; De Amici E; Fratino P; Solerte SB; Garzaniti A
    Int J Cardiol; 2006 Apr; 108(3):354-8. PubMed ID: 15961173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
    Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
    Scanu AM
    Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
    Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China.
    Sun L; Li Z; Zhang H; Ma A; Liao Y; Wang D; Zhao B; Zhu Z; Zhao J; Zhang Z; Wang W; Hui R
    Stroke; 2003 Jul; 34(7):1617-22. PubMed ID: 12791946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apolipoprotein (a)].
    Okubo M
    Nihon Rinsho; 1994 Dec; 52(12):3133-8. PubMed ID: 7853701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein(a) phenotypes in cardio-cerebrovascular diseases.
    Zhuang Y; Li J; Wang J
    Chem Phys Lipids; 1994 Jan; 67-68():293-7. PubMed ID: 8187226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels.
    Mancini FP; Mooser V; Guerra R; Hobbs HH
    Hum Mol Genet; 1995 Sep; 4(9):1535-42. PubMed ID: 8541836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of apolipoprotein (a) promoter from subjects with different plasma lipoprotein (a) concentrations.
    Wu JH; Lee IN
    Clin Biochem; 2003 Jun; 36(4):241-6. PubMed ID: 12810151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus.
    Kostner KM; Kostner GM
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New approach for lipids examination and its clinical significance. Part I. Apolipoprotein LP(a)].
    Kobayashi Y; Fukuo Y
    Nihon Ika Daigaku Zasshi; 1994 Aug; 61(4):343-6. PubMed ID: 8083340
    [No Abstract]   [Full Text] [Related]  

  • 39. A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians.
    Trommsdorff M; Köchl S; Lingenhel A; Kronenberg F; Delport R; Vermaak H; Lemming L; Klausen IC; Faergeman O; Utermann G
    J Clin Invest; 1995 Jul; 96(1):150-7. PubMed ID: 7615785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When should we measure lipoprotein (a)?
    Kostner KM; März W; Kostner GM
    Eur Heart J; 2013 Nov; 34(42):3268-76. PubMed ID: 23735860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.